Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA vs MEDS for Depression in Advanced Heart Failure
NCT03688100Phase 4Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Nov 2018
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (4 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Depressive Symptom Severity as Measured by the Patient Health Questionnaire (PHQ-9) Depression Scale Results at 6 months. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT03688100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688100.